Mind Medicine (MindMed) Inc. (MNMD)
NASDAQ: MNMD · Real-Time Price · USD
7.16
+0.15 (2.07%)
Dec 20, 2024, 4:00 PM EST - Market closed
Mind Medicine (MindMed) Market Cap
Mind Medicine (MindMed) has a market cap or net worth of $525.05 million as of December 20, 2024. Its market cap has increased by 311.80% in one year.
Market Cap
525.05M
Enterprise Value
254.08M
1-Year Change
311.80%
Ranking
Category
Stock Price
$7.16
Market Cap Chart
Since March 4, 2020, Mind Medicine (MindMed)'s market cap has decreased from $595.37M to $525.05M, a decrease of -11.81%. That is a compound annual growth rate of -2.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 525.05M | 257.80% |
| Dec 29, 2023 | 146.75M | 77.54% |
| Dec 30, 2022 | 82.66M | -85.99% |
| Dec 31, 2021 | 590.17M | -82.89% |
| Dec 31, 2020 | 3.45B | 479.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ginkgo Bioworks Holdings | 545.68M |
| Tourmaline Bio | 544.65M |
| Astria Therapeutics | 542.90M |
| CorMedix | 533.35M |
| Opthea | 531.74M |
| Semler Scientific | 525.33M |
| Xeris Biopharma Holdings | 523.90M |
| Phathom Pharmaceuticals | 521.72M |